We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PerkinElmer Acquires X-Ray Technology Company

By HospiMedica International staff writers
Posted on 04 Jul 2011
PerkinElmer, Inc. More...
(Waltham, MA, USA), a global company focused on the health and safety of people and the environment, announced that it has acquired Dexela, Ltd. (London, UK), a provider of flat panel complementary metal-oxide-semiconductor (CMOS) X-ray detection technologies and services.

The acquisition of Dexela expands PerkinElmer's current medical imaging range in key areas including surgery, dental CT, cardiology, and mammography, as well as nondestructive testing (NDT). With the addition of the CMOS technology to the company's imaging product range, customers will now be able to choose seamlessly between two complementary X-ray detector technologies to optimize their system performance and meet their specific application needs.

Dexela develops and commercializes its CMOS technology portfolio, which includes hardware and software offerings for fast, low-dose X-ray imaging. The company's CMOS products offer high spatial resolution frame rate and effectiveness, low noise, and absence of image lag. The Dexela technology is designed to provide high image quality, whether detecting defects in human tissue or industrial objects and structures, through design-friendly components that can be easily incorporated into an original equipment manufacturer (OEM) instrument or platform.

In addition to its CMOS X-ray detection units, Dexela technologies and services include its Dexela mammography workstation, the DexView image processing software, its three-dimensional (3D) reconstruction engine software, and consulting and implementation services.

"Dexela has been a pioneer in the development of CMOS X-ray detection solutions and has achieved award-winning recognition in the imaging market for its design strengths and ease of manufacturability, which are major advantages for OEM customers," said Brian Giambattista, president, medical imaging, PerkinElmer. "We look forward to expanding the reach of this promising technology into adjacent markets such as surgery, dental CT [computed tomography], cardiology, mammography, and industrial NDT, to detect, monitor, and remediate threats to human health or structural integrity."

Dexela is a developer of innovative technologies for fast, low-dose X-ray imaging. Formed in 2005, Dexela pioneered developments in breast tomosynthesis. In 2009, Dexela launched a family of flat panel CMOS X-ray detectors ideally suited to breast tomosynthesis and a range of other applications including mammography, fluoroscopy, dental cone beam CT (CBCT), cardiology, angiography, and bone densitometry, scientific instrumentation and nondestructive testing.

Related Links:

PerkinElmer
Dexela



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.